Ergoteles’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,123
Closed -$20.3K 952
2023
Q2
$20.3K Buy
+16,123
New +$26.1K ﹤0.01% 988
2021
Q4
Sell
-57,598
Closed -$214K 1684
2021
Q3
$214K Buy
57,598
+1,998
+4% +$8.53K 0.01% 955
2021
Q2
$332K Buy
+55,600
New +$294K 0.01% 1022

Other funds holding ARAV

Ergoteles's ARAV Position: Q3 2023 in Review

Ergoteles sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2023, closing a stake of 16,123 shares — an estimated $20.3K sold.

Ergoteles first reported a position in ARAV in Q2 2021 and held it in 3 quarters. The position peaked at $332K in Q2 2021. 33 funds tracked by Wall St. Rank hold ARAV as of Q3 2023.

  • Ergoteles reported no remaining Aravive, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 16,123 Aravive, Inc. Common Stock shares in Q3 2023, an estimated $20.3K.
  • Ergoteles first reported a position in Aravive, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Ergoteles's Aravive, Inc. Common Stock position peaked at $332K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.